MAPS Executive Director Predicts MDMA Assisted Therapy Will Be Approved “Sometime Around April-May 2024”

Jan 27, 2023

Potential For MDMA Assisted Therapy Approval Boosts Psychedelic Stocks Early In 2023

Jan 10, 2023

MAPS Clinical Trial Shows Follow-Up Positive Results For MDMA-Assisted Therapy

Jan 6, 2023

Numinus CEO Believes MDMA “Most Likely” To Be Approved At The End Of 2023

Dec 5, 2022

MAPS Completes Second Phase 3 Trial Of MDMA-Assisted Therapy For PTSD

Nov 18, 2022

Awakn’s Ben Sessa Tells All About MDMA and Netflix Docuseries

Aug 11, 2022

Mydecine Files Full Patent Application Covering MYCO-006 Family of Novel Short-Acting MDMA Analogs

Jul 19, 2022

MDMA Is What PharmAla Biotech Does, Says CEO Nick Kadysh

Jun 3, 2022

Numinus Completes First MDMA Administration in PTSD Trial Sponsored by MAPS

Mar 30, 2022

Numinus Wellness CEO Discusses MDMA And Psilocybin Trials

Mar 7, 2022